These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37788503)

  • 1. Molecular Imaging to Study Antimicrobial Pharmacokinetics In Vivo.
    Gordon O; Gobburu JVS; Dunn A
    J Infect Dis; 2023 Oct; 228(Suppl 4):S297-S301. PubMed ID: 37788503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Image-driven pharmacokinetics: nanomedicine concentration across space and time.
    Brill DA; MacKay JA
    Nanomedicine (Lond); 2015; 10(18):2861-79. PubMed ID: 26370694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Imaging: a Novel Tool To Visualize Pathogenesis of Infections
    Gordon O; Ruiz-Bedoya CA; Ordonez AA; Tucker EW; Jain SK
    mBio; 2019 Oct; 10(5):. PubMed ID: 31662452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography molecular imaging for drug development.
    Matthews PM; Rabiner EA; Passchier J; Gunn RN
    Br J Clin Pharmacol; 2012 Feb; 73(2):175-86. PubMed ID: 21838787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting phosphatidylserine for radionuclide-based molecular imaging of apoptosis.
    Wuest M; Perreault A; Richter S; Knight JC; Wuest F
    Apoptosis; 2019 Apr; 24(3-4):221-244. PubMed ID: 30684144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular imaging of targeted therapies with positron emission tomography: the visualization of personalized cancer care.
    Mammatas LH; Verheul HM; Hendrikse NH; Yaqub M; Lammertsma AA; Menke-van der Houven van Oordt CW
    Cell Oncol (Dordr); 2015 Feb; 38(1):49-64. PubMed ID: 25248503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular imaging in evaluation of in vivo behavior of drugs].
    Saji H
    Nihon Rinsho; 2007 Feb; 65(2):363-9. PubMed ID: 17302285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiolabeled inorganic nanoparticles for positron emission tomography imaging of cancer: an overview.
    Chakravarty R; Goel S; Dash A; Cai W
    Q J Nucl Med Mol Imaging; 2017 Jun; 61(2):181-204. PubMed ID: 28124549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular imaging-based early-phase and exploratory clinical research].
    Watanabe Y
    Yakugaku Zasshi; 2013; 133(2):187-95. PubMed ID: 23370512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4
    Kristensen LK; Fröhlich C; Christensen C; Melander MC; Poulsen TT; Galler GR; Lantto J; Horak ID; Kragh M; Nielsen CH; Kjaer A
    Theranostics; 2019; 9(26):8221-8238. PubMed ID: 31754392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic-Derived Radiotracers for Positron Emission Tomography: Nuclear or "Unclear" Infection Imaging?
    Gouws AC; Kruger HG; Gheysens O; Zeevaart JR; Govender T; Naicker T; Ebenhan T
    Angew Chem Int Ed Engl; 2022 Nov; 61(45):e202204955. PubMed ID: 35834311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vivo imaging of liposomal small interfering RNA (siRNA) trafficking by positron emission tomography].
    Ando H; Yonenaga N; Asai T; Hatanaka K; Koide H; Tsuzuku T; Harada N; Tsukada H; Oku N
    Yakugaku Zasshi; 2012; 132(12):1373-81. PubMed ID: 23208044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET Imaging in Psychoneuroimmunology Research.
    Hannestad J
    Methods Mol Biol; 2018; 1781():287-307. PubMed ID: 29705853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matching Chelators to Radiometals for Positron Emission Tomography Imaging- Guided Targeted Drug Delivery.
    Deng H; Wang H; Li Z
    Curr Drug Targets; 2015; 16(6):610-24. PubMed ID: 26148988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microdosing studies in humans: the role of positron emission tomography.
    Bauer M; Wagner CC; Langer O
    Drugs R D; 2008; 9(2):73-81. PubMed ID: 18298126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of Early Response Monitoring and Prediction of Cancer Antiangiogenesis Therapy via Noninvasive PET Molecular Imaging Strategies of Multifactorial Bioparameters.
    Bao X; Wang MW; Luo JM; Wang SY; Zhang YP; Zhang YJ
    Theranostics; 2016; 6(12):2084-2098. PubMed ID: 27698942
    [No Abstract]   [Full Text] [Related]  

  • 17. Positron emission tomography for use in microdosing studies.
    Wagner CC; Müller M; Lappin G; Langer O
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):104-10. PubMed ID: 18175273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-Based PET Radiotracers.
    D'Souza JW; Hensley H; Doss M; Beigarten C; Torgov M; Olafsen T; Yu JQ; Robinson MK
    J Nucl Med; 2017 Jan; 58(1):175-180. PubMed ID: 27539844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Molecular Imaging with 2-Deoxy-2-[Fluorine-18] Fluoro-DGlucose Positron Emission Tomography (18F-FDG PET) for Small Cell Lung Cancer (SCLC): A Radiation Oncology Perspective.
    Sager O; Dincoglan F; Demiral S; Uysal B; Gamsiz H; Elcim Y; Gundem E; Dirican B; Beyzadeoglu M
    Curr Radiopharm; 2019; 12(1):4-10. PubMed ID: 30465520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting brain concentrations of drug using positron emission tomography and venous input: modeling of arterial-venous concentration differences.
    Syvänen S; Blomquist G; Appel L; Hammarlund-Udenaes M; Långström B; Bergström M
    Eur J Clin Pharmacol; 2006 Oct; 62(10):839-48. PubMed ID: 16896783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.